They sue me because the medicine is illegal, but if it is legal, they say I can't afford it?

Chapter 339 Closing the Net

……

“Keep your eye on this project.”

"Also, let our market research department follow up on this project."

"If we can't reach an agreement with Pfizer, and the price is within our acceptable range, we can try to get it."

After putting down the research report, Anna quickly made a decision.

Of course, she hoped to acquire Chen Xuan's drug patent, but this opportunity obviously no longer existed, so she naturally had to shift her target to other drug patents.

The anti-cancer drug that Pfizer has discovered now does have great potential and is worth acquiring.

However, there are also unspoken rules among pharmaceutical giants. Generally, they will not compete for the same project casually. The emphasis is on first come first served.

After all, if multiple giants compete for a project, a project that was originally worth $100 billion may eventually be competed for $10 billion.

In order to avoid this kind of malicious competition, we have to adopt the implicit rule of first come first served.

Of course, if you really come across a high-quality project that is guaranteed to make money, then there will be no such thing as unspoken rules.

As long as core interests are involved, no pharmaceutical company will care about first come first served. It is not a big deal to just fall out with each other. Just get the benefits first.

But for general interests, there is no need to go to this extent.

Anna suggested this just to give it a try.

Given Pfizer's current situation, it is basically impossible for it to give up on such a high-quality anti-cancer project.

Therefore, Novartis has no chance of picking up a bargain, and she does not hold out much hope. She is mainly keeping an eye on it and does not expect that it will be her turn to acquire it.

But it doesn't matter what.

Pfizer's sudden attention to this project has also attracted attention from all parties.

Everyone is researching this anti-cancer project. How big is the future market and is it really worth investing in?

After all, many people know that Pfizer wants to make a comeback with this project, so naturally they need to understand the latest situation.

……

And about Pfizer's plan to acquire an anti-cancer drug project.

Chen Xuan is also concerned about this and is now considering this issue.

After all, he is shorting Pfizer, and if there is good news, it will definitely be detrimental to his shorting.

“Whatever happens with this project is fine.”

"But if Pfizer really acquires it, it will definitely be portrayed as good news."

"By then, Pfizer's stock price will also rise rapidly. Even if it falls back later, it will not be conducive to my current short selling."

After some analysis, Chen Xuan had an idea in his mind.

It seems that even if the project is eventually declared a failure, good news can still be released continuously before the announcement of failure.

In addition, Pfizer's operations are enough to push up the stock price. No one can predict how high it can rise, but it will definitely be much higher than it is now.

So in order not to take any risks, he decided to quit while he was ahead.

End the short selling first, and then consider whether to continue short selling after Pfizer's surge.

Anyway, if he ends his short selling now, he can make a lot of money, so there is no need to take such a big risk.

Chen Xuan is never a hesitant person. Once he has an idea in his mind, he will take action immediately.

Soon, this short selling was also a perfect closed loop without any problems.

"Pfizer's market value has recently evaporated by more than $40 billion, and now it is only $160 billion, a drop of 15 percent."

Looking at these data, Chen Xuan was still very happy.

Although Pfizer's decline rate was not as fast as that of Dasheng Pharmaceutical Group, more money evaporated than that of Dasheng Pharmaceutical Group.

"Twenty billion."

"One short sale yielded 20 billion, a 200% return."

"No wonder Pfizer is so anxious. Their situation is indeed very grim, but can this project really save Pfizer?"

Chen Xuan was also very satisfied with the profits from this short selling.

Pfizer's market value evaporated by more than 200 billion yuan, and he also earned 20 billion yuan from short selling.

This is already a very considerable income. Even after deducting the handling fees and so on, the actual income is more than 100 billion.

Therefore, he had nothing to be dissatisfied with. Few people could achieve such short-selling profits.

It’s also because of this short selling.

This made Chen Xuan understand Pfizer's feelings better.

Faced with such large fluctuations in the stock market, it is difficult to recover from anxiety. Any listed company would be so anxious.

After all, the ups and downs in the stock market are just a number, but if this number lasts too long, it will turn into a real loss of money.

……